Optometry Equipment Market to Reach US$ 9.6 billion by 2034 at a 6.5% CAGR

The global optometry equipment market is witnessing a technological renaissance, projected to grow from US$ 5.1 billion in 2024 to US$ 9.6 billion by 2034. According to the latest industry analysis by Fact.MR, this steady 6.5% CAGR is being fueled by a “perfect storm” of demographic shifts—specifically a rising geriatric population—and a global spike in chronic metabolic diseases like diabetes.

With at least 2.2 billion people currently living with vision impairment, healthcare providers are aggressively pivoting toward automated, AI-driven diagnostic tools. The goal is clear: faster testing turnarounds and early intervention to prevent irreversible vision loss from conditions such as glaucoma and diabetic retinopathy.

Quick Stats: Optometry Equipment Market at a Glance

• Market Value (2024E): US$ 5.1 Billion
• Projected Value (2034F): US$ 9.6 Billion
• Global Growth Rate:5% CAGR (2024–2034)
• Glaucoma Surgery Devices (2034F): US$ 2.3 Billion
• Hospital Outpatient Segment (2034F): US$ 2.1 Billion
• North America Market Share (2034F):3%

Strategic Drivers: Diabetes and the Digital Revolution

The market is no longer just about vision correction; it is becoming a critical front in chronic disease management.

The Diabetes Connection:

With approximately 422 million people living with diabetes globally, the incidence of diabetic retinopathy (DR) is expected to soar to 160.5 million by 2045. This has triggered a massive demand for advanced ophthalmic imaging and screening devices equipped with high-speed data processing algorithms. Pharmaceutical leaders like Novartis AG are already reporting breakthroughs in treating diabetic macular edema, further driving the need for sophisticated screening infrastructure.

Digital Eye Strain & Myopia:

The “digital revolution” has come at a cost. With over 85% of the world using smartphones, excessive screen time is leading to a global surge in dry eyes, redness, and myopia—particularly in children. Manufacturers are responding with innovations like Carl Zeiss AG’s BlueGuard lenses and HAAG-STREIT’s Lenstar Myopia management systems to combat the effects of the “new normal.”

Regional Performance: North America and East Asia Lead the Charge

While North America maintains a significant foothold, East Asian markets are exhibiting rapid acceleration due to aging populations and specialized research hubs.

Category Insights: Hospital Outpatients and Surgical Sophistication

• Hospital Outpatients (US$ 2.1 Billion by 2034): This segment remains the primary end user. Patients are increasingly favoring hospital-based clinics due to the availability of skilled experts and the latest cutting-edge diagnostic technologies under one roof.
• Glaucoma Surgery Devices (6.6% CAGR): As the leading cause of irreversible blindness, glaucoma is driving intense R&D. Manufacturers are leveraging breakthroughs in micro-tooling and laser precision to offer more sophisticated surgical outcomes.

The Start-up Ecosystem: Deep Learning and Portability

The industry is being disrupted by agile start-ups focusing on computer vision. U.S.-based Altris is utilizing deep learning algorithms for real-time retinal diagnosis, while Switzerland’s MIKAJAKI offers an “Arine Ophthalmology” suite for pre-diagnostic screening. These players are filling the gap for accessible, “decision-support” platforms in primary care settings.

Analyst Opinion:

“We are moving away from manual, subjective eye exams toward an era of ‘Predictive Optometry.’ By integrating AI and IoT, equipment is now capable of identifying micro-vascular changes years before a patient notices vision loss. This shift from treatment to proactive screening is what will define the next decade of the market.” — Senior Market Analyst, Fact.MR

Browse Full Report:

https://www.factmr.com/report/363/optometry-equipment-market